Showing results (1331-1340 of 9,979) with videos related to

Sort By:
Pageof 998
Leukemia & Lymphoma|December 30, 1998
Anti-CD16/CD30 bispecific antibodies as possible treatment for refractory Hodgkin's diseaseF Hartmann, C Renner, W Jung, et al.
Leukemia & Lymphoma|December 11, 2007
Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myelomaRuben Niesvizky, Déborah Martínez-Baños, Jessica Jalbrzikowski, et al.
Leukemia & Lymphoma|December 11, 2007
Paclitaxel and filgrastim for hematopoietic progenitor cell mobilization in patients with hematologic malignancies after failure of a prior mobilization regimenTrevor McKibbin, Julianna Burzynski, Rebecca Greene, et al.
Leukemia & Lymphoma|December 11, 2007
Biologic predictors in follicular lymphoma: importance of markers of immune responseTodd Kelley, Rose Beck, Ahmed Absi, et al.
Leukemia & Lymphoma|December 11, 2007
Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic featuresDeborah A Bowen, Timothy G Call, Greg D Jenkins, et al.
Leukemia & Lymphoma|December 11, 2007
Specific pattern of protein expression in acute myeloid leukemia harboring FLT3-ITD mutationsSebastian Scholl, Christian Melle, Annett Bleul, et al.
Leukemia & Lymphoma|October 9, 2009
Haploidentical hematopoietic stem-cell transplantation for non-Hodgkin lymphoma with bone marrow involvementHeng-Xiang Wang, Hong-Min Yan, Jing Liu, et al.
Leukemia & Lymphoma|February 11, 2014
Challenges and new prospects in hepatosplenic γδ T-cell lymphomaMarco Calvaruso, Alessandro Gulino, Salvatore Buffa, et al.
Leukemia & Lymphoma|February 5, 2014
Long-term effect of curcumin down-regulates expression of tumor necrosis factor-α and interleukin-6 via modulation of E26 transformation-specific protein and nuclear factor-κB transcription factors in livers of lymphoma bearing miceLaxmidhar Das, Manjula Vinayak
Leukemia & Lymphoma|January 21, 2025
Therapeutic approach to patients with early stage diffuse large B cell lymphoma: retrospective, multicenter, real-life study of the 'RTL' (regional Tuscan lymphoma network)Emanuele Cencini, Marianna Palazzo, Dimitri Dardanis, et al.
Pageof 998